Galactose binds to focal segmental glomerulosclerosis permeability factor and inhibits its activity (Q46566229)

23 December 2017

title

Galactose binds to focal segmental glomerulosclerosis permeability factor and inhibits its activity (English)

1 reference

23 December 2017

focal segmental glomerulosclerosis

main subject

1 reference

1

Virginia J Savin

1 reference

23 December 2017

Ellen T. McCarthy

2

object named as

Ellen T McCarthy

1 reference

23 December 2017

Ram Sharma

3

object named as

Ram Sharma

1 reference

23 December 2017

author name string

Deane Charba

4

1 reference

23 December 2017

Mukut Sharma

5

1 reference

23 December 2017

publication date

2 May 2008

1 reference

23 December 2017

published in

Translational Research

1 reference

23 December 2017

volume

151

1 reference

23 December 2017

issue

6

1 reference

23 December 2017

page(s)

288-292

1 reference

23 December 2017

Mechanisms of disease: focal segmental glomerulosclerosis

cites work

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2008.04.001

Recurrence of nephrotic syndrome/focal segmental glomerulosclerosis following renal transplantation in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2008.04.001

Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2008.04.001

Plasma immunadsorption treatment in patients with primary focal and segmental glomerulosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2008.04.001

Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2008.04.001

Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2008.04.001

Proteinuria after injection of human focal segmental glomerulosclerosis factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2008.04.001

The focal segmental glomerulosclerosis permeability factor: biochemical characteristics and biological effects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2008.04.001

Serum permeability activity in steroid-resistant minimal change nephrotic syndrome is abolished by treatment of Hodgkin disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2008.04.001

Serial Estimates of Serum Permeability Activity and Clinical Correlates in Patients with Native Kidney Focal Segmental Glomerulosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2008.04.001

Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis in native kidneys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2008.04.001

Podocalyxin activates RhoA and induces actin reorganization through NHERF1 and Ezrin in MDCK cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2008.04.001

Glycans as endocytosis signals: the cases of the asialoglycoprotein and hyaluronan/chondroitin sulfate receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2008.04.001

Improvement in cardiac function in the cardiac variant of Fabry's disease with galactose-infusion therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2008.04.001

10.1016/J.TRSL.2008.04.001

7 January 2021

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017